SHEENA ESLINGER: Open Payments
NPI 1942675673 · MARYVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,621 in 192 payments from 17 companies in 2025. Trend: 2023 $2,479 · 2024 $3,177 · 2025 $3,621
Food & beverage: $3,610Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 56 | $1,100 |
| Janssen Biotech, Inc. | 26 | $414 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $368 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 15 | $320 |
| PFIZER INC. | 21 | $227 |
| Ardelyx, Inc. | 16 | $226 |
| Lilly USA, LLC | 9 | $213 |
| QOL Medical, LLC | 8 | $189 |
| Regeneron Healthcare Solutions, Inc. | 5 | $152 |
| Gilead Sciences, Inc. | 5 | $114 |
Products named: RINVOQ, TREMFYA, SKYRIZI, ENTYVIO, XIFAXAN, DUPIXENT, IBSRELA, OMVOH.
Industry payments across IL — which companies pay providers there.
